TAK Takeda Pharmaceutical
- 14.260
- +0.180+1.28%
Takeda Pharmaceutical News
6-K: Earnings Report for the Three-month Period Ended June 30, 2024
6-K: Corporate Governance Report
6-K: 2024 Annual Integrated Report
20-F: FY2024 Annual Report
6-K: Notice of Resolutions at the 148th Ordinary General Meeting of Shareholders
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
Takeda Pharmaceutical | 6-K: Quarterly Securities Report For The Nine-month Period and Three-month Quarter Ended December 31, 2023
Takeda Pharmaceutical | 6-K: Summary of Financial Statements for the Nine-month Period Ended December 31, 2023
Takeda Pharmaceutical | 6-K: Partial Amendment to Corporate Governance Report
Takeda Pharmaceutical | 6-K: The 147th (interim period) Business Report
Takeda Pharmaceutical | 6-K: Report of foreign private issuer (related to financial reporting)
Takeda Pharmaceutical | 6-K: Report of foreign private issuer (related to financial reporting)
Takeda Pharmaceutical | 6-K: Report of foreign private issuer (related to financial reporting)
Analysis
Price Target
No Data
No Data
